SAB Biotherapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: SAB Biotherapeutics Inc: Is Infosys Ltd. worth buying?
Item: SAB Biotherapeutics Inc
Rating: 1.34633325
Author: Trendlyne DVM scores

about

SAB Biotherapeutics Inc is a clinical-stage biopharmaceutical company focused on developing multi-specific, high-potency, human immunoglobulin G (hIgG) to treat and prevent immune and autoimmune disorders. The company's lead product candidate, SAB-14...

3.70 -0.19 (-4.88%)

43.94% Fall from 52W High

942.4K

XNAS Volume

XNAS 15 May, 2026 5:30 PM (EDT)

Not Eligible

Expensive Valuation

10.3 / 100

Technically Neutral

43.5 / 100

No estimates available

SAB Biotherapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

SAB Biotherapeutics Inc Live Stock Price Today, Share Analysis and Chart

SAB Biotherapeutics Inc is a clinical-stage biopharmaceutical company focused on developing multi-specific, high-potency, human immunoglobulin G (hIgG) to treat and prevent immune and autoimmune disorders. The company's lead product candidate, SAB-14...

43.94% Fall from 52W High

SWOT Analysis

SAB Biotherapeutics Inc Live Price Chart